Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The European Patent Office, or the EPO, has upheld a patent owned by Exact Sciences pertaining to aspects of its DNA technologies. The decision by the EPO's opposition division was in response to a challenge by a major diagnostics company seeking to invalidate the patent claims.
Subscribe to our email newsletter
Exact Sciences has a portfolio of over 110 issued patents and over 60 pending patent applications in the US, Europe, Japan, Canada, Australia and elsewhere.
Jeffrey Luber, president of Exact Sciences, said: “We are very pleased with the decision of the EPO in support of our European patent, one of the many patents in our broad intellectual property portfolio that covers a wide range of technologies relating to cancer detection. We believe this ruling is further evidence of the strength of our patent position and our commitment to vigorously defending and enforcing our intellectual property rights worldwide.”